Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

Sara M. Tolaney, Valentina Guarneri, Jae Hong Seo, Josefina Cruz, Miguel Henriques Abreu, Masato Takahashi, Carlos H. Barrios, Kristi McIntyre, Ran Wei, María del Mar Muñoz, Belén San Antonio, Astra M. Liepa, Miguel Martín, Stephen Johnston, Pirkko‐Liisa Kellokumpu‐Lehtinen, Nadia Harbeck